Your browser doesn't support javascript.
loading
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
Davey, Christopher G; Chanen, Andrew M; Hetrick, Sarah E; Cotton, Sue M; Ratheesh, Aswin; Amminger, Günter P; Koutsogiannis, John; Phelan, Mark; Mullen, Edward; Harrison, Ben J; Rice, Simon; Parker, Alexendra G; Dean, Olivia M; Weller, Amber; Kerr, Melissa; Quinn, Amelia L; Catania, Lisa; Kazantzis, Nikolaos; McGorry, Patrick D; Berk, Michael.
Affiliation
  • Davey CG; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia; Orygen Youth Health, Melbourne Health, Melbourne, VIC, Australia. Electronic address: c.davey@unimelb.edu.au.
  • Chanen AM; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia; Orygen Youth Health, Melbourne Health, Melbourne, VIC, Australia.
  • Hetrick SE; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia; Department of Psychological Medicine, University of Auckland, Auckland, New Zealand.
  • Cotton SM; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia.
  • Ratheesh A; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia; Orygen Youth Health, Melbourne Health, Melbourne, VIC, Australia.
  • Amminger GP; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia.
  • Koutsogiannis J; Orygen Youth Health, Melbourne Health, Melbourne, VIC, Australia.
  • Phelan M; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia; Orygen Youth Health, Melbourne Health, Melbourne, VIC, Australia.
  • Mullen E; Orygen Youth Health, Melbourne Health, Melbourne, VIC, Australia.
  • Harrison BJ; Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne, Melbourne, VIC, Australia.
  • Rice S; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia; Orygen Youth Health, Melbourne Health, Melbourne, VIC, Australia.
  • Parker AG; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia; Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia.
  • Dean OM; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia; Deakin University, IMPACT Strategic Research Centre, School of Medicine, Geelong, VIC, Australia.
  • Weller A; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia.
  • Kerr M; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia.
  • Quinn AL; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia.
  • Catania L; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia.
  • Kazantzis N; Cognitive Behaviour Therapy Research Unit, School of Psychological Sciences and Institute of Cognitive and Clinical Neurosciences, Monash University, Melbourne, VIC, Australia.
  • McGorry PD; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia; Orygen Youth Health, Melbourne Health, Melbourne, VIC, Australia.
  • Berk M; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia; Deakin University,
Lancet Psychiatry ; 6(9): 735-744, 2019 09.
Article in En | MEDLINE | ID: mdl-31371212
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Cognitive Behavioral Therapy / Fluoxetine / Combined Modality Therapy / Depression / Depressive Disorder, Major Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male Country/Region as subject: Oceania Language: En Journal: Lancet Psychiatry Year: 2019 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Cognitive Behavioral Therapy / Fluoxetine / Combined Modality Therapy / Depression / Depressive Disorder, Major Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male Country/Region as subject: Oceania Language: En Journal: Lancet Psychiatry Year: 2019 Document type: Article